Daily Dose - Aug 22nd, 2023
 
 
Daily Dose | View online
 
August 22, 2023
Today's Top Story
The U.S. FDA hit a five-year approval low last year, greenlighting just 37 novel drugs. But if the agency keeps its current pace, approval numbers seem poised for recovery in 2023. Here are a few decisions that stand out from the crowd.
Industry News
Already approved for older adults, Abrysvo is now cleared for use in pregnant individuals.
On the heels of a disappointing phase 3 trial, the biotech is looking for strategic alternatives.
Sponsored

Global Biosimilars Week is a social media campaign inviting patients, stakeholders, healthcare professionals and their organizations around the world to share resources and information about biosimilar medicines using our hashtag #GlobalBiosimilarsWeek. This year, our theme is Making Cancer Care More Accessible to Patients and Healthcare Systems.

Sponsored

With more than 40,000 visitors casting their eyes over the stands of 1,800 exhibitors, CPHI Barcelona, is the place to see and be seen. This is where you discover the partners that will help drive your business forwards – and where they find you.

 

Sponsored

This technical whitepaper sheds light on how MQTT Sparkplug specification offers a comprehensive approach to address data connectivity and interoperability challenges specific to Pharma Manufacturing.